GOPAL — Deck
Gopal Snacks · GOPAL · NSE
Gopal Snacks is a Rajkot-based ethnic Indian snack maker — gathiya, namkeen, wafers, snack pellets — selling roughly 63% of its volume in $0.06 sachets through 881 distributors, mostly in Gujarat.
$2.95
Price
$368M
Market cap
$172M
Revenue (FY25)
Mar 2024
Listed (NSE/BSE)
Listed at $4.34 in March 2024; ramped to $6.09 by November on a 12% margin print; crashed to $2.90 after a December 2024 plant fire halved earnings; now $2.95 — 23% below listing.
2 · The tension
Pricing a Bikaji-class recovery management has serially walked back.
- Margin collapse, not growth collapse. Operating margin fell from 14% (FY23 peak) to 12% (FY24, IPO disclosure year) to 7% in FY25 after a 54% palm-oil spike ($0.99→$1.54/kg) and a Rajkot fire that knocked out 65% of capacity. Pre-fire FY25 was already drifting to 11.6% versus a 12–13% guide.
- 97× trailing on a fire-distorted base. FY25 PAT collapsed 81% on a $5.5M exceptional charge against $11M stated total loss. Strip the fire and the multiple is 35× on FY24 EPS of $0.10 — still trading through Bikaji's 65× despite weaker margins, weaker scale, and 70% Gujarat concentration.
- One date resolves the debate: May 12, 2026. The Q4 FY26 audited print lands in 14 days — Q4 EBITDA, FY27 guidance check, dividend signal, and final insurance reconciliation in one shot. Management has guided 'near double-digit' exit; consensus models 10–12%.
FY24's 12% operating margin was either a structural mean to revert to — or a pre-IPO peak built on inventory and capex management. May 12 settles it.
3 · Where we disagree with the market
Q4 FY26 is the wrong binary — the real read lands in August.
- Insurance is flowing above the operating line. Of a $20.9M cover against $11M stated loss, only $4.2M has been recovered through Q3 FY26 — leaving $4M in flight. Q3 FY26's 7.6% EBITDA included $2.4M of insurance booked above the line. A 10–12% Q4 headline can co-exist with a 7–8% clean read.
- The right peer is Prataap, not Bikaji. Consensus targets of $3.95–$4.26 anchor on a Bikaji-style 30–35× of normalized EPS. But Gopal's structural attributes — 70% Gujarat, 63% from $0.06 sachets, FY27 ambition halved from 14% to 8–9% — match Prataap (4% EBITDA, being acquired by Haldiram). A Prataap-comp EV/sales puts fair value near $1.76.
- Price action is already pricing the bear. Brokerage average $4.09 implies +39% upside; the actual stock sits 47% below its November 2024 high, FII holding has collapsed 3.18% → 0.71%, and retail count halved. The marginal seller is institutional, and consensus is loudest where it has the smallest dollar weight.
Don't mark the stock on May 12 EBITDA. Mark it on Q1 FY27 in August — the first quarter when the insurance cycle is closed and the underlying margin is observable without a tailwind.
4 · Money picture
Revenue inches forward; margin and free cash flow do the violent work.
$172M
Revenue FY25
+5% YoY, 5.7% CAGR FY22–25
7.2%
Operating margin FY25
FY23 peak: 14.1%
$9M
Cumulative FCF (FY20–25)
vs $42M cumulative net income
97×
P/E (TTM)
35× on FY24 clean EPS
Revenue has held a $37–47M quarterly corridor for thirteen straight quarters — this is a margin story, not a growth story. Cash conversion looked fine on average until the IPO year, when CFO/NI dropped to 0.69 as inventory days went to 75 and capex sat below depreciation. FCF has been negative or breakeven in four of the last six years; the asset-turn engine keeps demanding plant capex to grow, and free cash flow only matters again if EBITDA recovers above 10%.
5 · The IPO setup the playbook flags
Forensic risk is structural, not deceptive — but the pattern is exactly the textbook one.
- 100% offer-for-sale, $78M to the family. The March 2024 IPO was pure liquidity for promoters — Gopal Agriproducts $65M, Bipin Hadvani $12M. Zero fresh capital reached the company. Promoter incentives align with the last reported pre-listing year (FY23, the 14% margin peak), not future operating performance.
- Inventory days 30 → 75 into the IPO window. Inventory built 150% across FY22–FY24 against revenue growth of 4%, then collapsed to 51 in FY25 (partly fire-destroyed). Management defends it as crop-cycle stocking — but in a snack maker with 30–45 day shelf life, the build flatters IPO-year cost absorption.
- CFO exit timed to the fire. Mukesh Shah resigned 21 January 2025 — 41 days after the December fire, 70 days before the year-end. Q4 FY25 then booked a $5.5M exceptional against management-stated $11M total loss; the gap flows through operating P&L as lost revenue, while recoveries come back as positive exceptional income in FY26.
Pre-IPO peak, OFS exit, post-IPO reset, concentrated exceptional charge, CFO change in the gap. The proximate cause is a real fire and a real cost shock — the structure is what the playbook says to watch.
6 · The tail risk consensus isn't pricing
A 9.72% promoter pledge into 0.06%-of-market-cap daily liquidity.
- Founder pledged 12.1M shares to Tata Capital. On 24 March 2026 Bipin Hadvani added another 1.62M shares to the encumbrance, taking total pledge to 9.72% of the company (~$36M) — against a personal loan with no disclosed operating use of proceeds. Promoter holding sits at 81.46%; total free float is small.
- Not institutionally implementable. Average daily traded value is $224k — 0.06% of market cap. A 1% issuer-level position takes 81 trading days to exit at 20% ADV participation. Practical buyers are specialist micro-cap PMS / family-office capital under ~$4–5M AUM at a 5% weight.
- Distributed ownership is leaving. FII holding collapsed from 3.18% at IPO to 0.71% in March 2026; shareholder count fell from 134,000 post-IPO to ~67,000 — a speculative retail exodus. A further 25–30% drawdown plausibly triggers a margin call on the pledged stock into an orderbook that cannot absorb it.
This is the single largest source of disorderly downside left in the structure that does not show up on the earnings line.
7 · Bull and Bear
Watchlist — paying 97× trailing for a binary that resolves in 14 days does not earn the wait.
- For. Mean reversion is mechanical: palm oil normalized to $1.17–$1.23/kg, Modasa Phase II live from December 2025, quarterly EBITDA tracking 1% → 5% → 6% → 8% from the Q4 FY25 trough.
- For. Bikaji discount is real: same product, same channel, same niche; ~$4M of insurance recoveries plausibly remain as a free FY26 EPS uplift.
- Against. Guidance has been gutted, not just missed: FY27 ambition reset from $256M / 14% (Oct-2024) to $200–212M / 8–9% (Jan-2026); 10 of 12 quantified post-IPO promises missed or reset.
- Against. The 9.72% Tata Capital pledge into a 0.06%-ADV float is a discontinuous forced-seller mechanism — not a smooth governance discount.
Lean cautious. The Bear carries the weight of evidence, but a Q4 FY26 print at ≥9% EBITDA on a clean ex-recovery basis would flip the verdict to Lean Long; ≤8% with recoveries above the line slides it to Lean Short.
Watchlist to re-rate: May 12: Q4 FY26 EBITDA stripped of insurance, and direction of dividend. Next quarterly SAST: any further pledge to Tata Capital. Q1 FY27 (August): non-Gujarat revenue mix and wafer growth on a clean base.